VISIT US IN CHICAGO JUNE 2-4 AT BOOTH 2073!

Search Videos by Topic or Participant
Browse by Series:

Options in Unresectable Metastatic Colorectal Cancer

Insights From:Tanios Bekaii-Saab, MD, Ohio State University-James Cancer Hospital; Cathy Eng, MD, FACP, MD Anderson Cancer Center; John L. Marshall, MD, Georgetown University Medical Center
Published: Wednesday, Sep 23, 2015


Patient follow-up depends upon the stage of the colorectal cancer (CRC) as well as whether they are actively receiving treatment, radiation, or planning for surgery, states Cathy Eng, MD. A patient with early stage disease who has already had surgery is typically then treated with 6 months of chemotherapy. Communicating with patients regarding the extent of their treatment is important so that they can more easily make personal decisions, says Eng.

Metastatic CRC cannot be surgically cured, and chemotherapy is continued indefinitely for those who tolerate treatment and have appropriate laboratory values. These patients have incurable residual disease, and chemotherapy is given to prolong their lives, comments Eng. Individuals often need treatment breaks, which are typically given for 2 to 6 weeks.

It is difficult to tell patients that you cannot cure their disease, says John L. Marshall, MD. Oncologists should explain that the goal of therapy is to maintain a high quality of life, while also controlling the disease and minimizing toxicities. There is often a clinical trial available, adds Marshall.
Slider Left
Slider Right


Patient follow-up depends upon the stage of the colorectal cancer (CRC) as well as whether they are actively receiving treatment, radiation, or planning for surgery, states Cathy Eng, MD. A patient with early stage disease who has already had surgery is typically then treated with 6 months of chemotherapy. Communicating with patients regarding the extent of their treatment is important so that they can more easily make personal decisions, says Eng.

Metastatic CRC cannot be surgically cured, and chemotherapy is continued indefinitely for those who tolerate treatment and have appropriate laboratory values. These patients have incurable residual disease, and chemotherapy is given to prolong their lives, comments Eng. Individuals often need treatment breaks, which are typically given for 2 to 6 weeks.

It is difficult to tell patients that you cannot cure their disease, says John L. Marshall, MD. Oncologists should explain that the goal of therapy is to maintain a high quality of life, while also controlling the disease and minimizing toxicities. There is often a clinical trial available, adds Marshall.
View Conference Coverage
Online CME Activities
TitleExpiration DateCME Credits
34th Annual Miami Breast Cancer Conference® Clinical Case Vignette Series™May 25, 20182.0
Community Practice Connections™: CDK4/6 Inhibitors With the Experts: The Role of Emerging Agents for the Management of Metastatic Breast CancerMay 30, 20182.0
Publication Bottom Border
Border Publication
x